Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    1301 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
    1302 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Denmark 72
    1303 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 56
    1304 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 63
    1305 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 68
    1306 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 53
    1307 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 70
    1308 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 14
    1309 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 57
    1310 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Poland 49
    1311 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Russian Federation 43
    1312 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 76
    1313 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Belgium 63
    1314 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 63
    1315 Apheresis Allogeneic Other Leukemia, Specify, CNL Hematology 2025 Standard Therapy USA 70
    1316 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 53
    1317 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Iran 8
    1318 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 21
    1319 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Denmark 65
    1320 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Romania 25
    1321 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 27
    1322 Apheresis Allogeneic Polycythaemia Vera Hematology 2025 Standard Therapy Germany 61
    1323 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 25
    1324 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 51
    1325 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 70
    1326 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 53
    1327 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 61
    1328 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russian Federation 49
    1329 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 36
    1330 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 62
    1331 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 54
    1332 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 74
    1333 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Poland 49
    1334 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 62
    1335 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 74
    1336 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Argentine 57
    1337 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 56
    1338 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Belgium 71
    1339 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Spain 59
    1340 Apheresis Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2025 Standard Therapy USA 65
    1341 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 14
    1342 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Denmark 57
    1343 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
    1344 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 51
    1345 Apheresis Allogeneic Richter Transformation CDLBCC Hematology 2025 Standard Therapy Germany 68
    1346 Apheresis Allogeneic Acute Myelogenous Leukemia-MR Hematology 2025 Standard Therapy Russian Federation 16
    1347 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
    1348 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 66
    1349 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 50
    1350 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 38
    1351 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 43
    1352 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 74
    1353 Apheresis Allogeneic T-cell Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 51
    1354 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 59
    1355 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 66
    1356 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
    1357 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 33
    1358 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 48
    1359 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Netherlands 66
    1360 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 57
    1361 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy Belgium 56
    1362 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
    1363 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 24
    1364 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 61
    1365 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
    1366 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 53
    1367 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 62
    1368 Apheresis Autologous Mantle Cell Lymphoma Hematology 2025 Standard Therapy Germany 45
    1369 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 61
    1370 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 32
    1371 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2025 Standard Therapy Germany 62
    1372 Apheresis Autologous Central Nervous System Lymphoma Hematology 2025 Standard Therapy Germany 75
    1373 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 70
    1374 Cord Tissue Autologous Autism Neurology 2024 Experimental Therapy Romania 6
    1375 Cord Tissue Allogeneic – Related Autism Neurology 2024 Experimental Therapy Romania 6
    1376 Cord Tissue Autologous Autism Neurology 2024 Experimental Therapy Romania 4
    1377 Cord Tissue Allogeneic – Related Autism Neurology 2024 Experimental Therapy Romania 6
    1378 Cord Tissue Allogeneic – Unrelated Degenerative and Traumatic Cartilage Orthopedics 2024 Experimental Therapy Poland 50,3
    1379 Cord Tissue Allogeneic – Unrelated Degenerative and Traumatic Cartilage Orthopedics 2024 Experimental Therapy Poland 49,5
    1380 Cord Tissue Allogeneic – Unrelated Degenerative and Traumatic Cartilage Orthopedics 2024 Experimental Therapy Poland 58,11
    1381 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2024 Experimental Therapy Poland 7,7
    1382 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2024 Experimental Therapy Poland 15,7
    1383 Cord Tissue Allogeneic – Unrelated Ovarian Dysfunction Gynecology 2024 Experimental Therapy Poland 48,1
    1384 Cord Tissue Allogeneic – Related Severe Pulmonary Hypertension +Mitral Regurgitation Cardiovascular/Pulmonary 2024 Experimental Therapy Romania 2,6
    1385 Cord Tissue Allogeneic – Unrelated Amyotrophic lateral sclerosis Neurology 2024 Experimental Therapy Poland 57,6
    1386 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2024 Experimental Therapy Poland 68,2
    1387 Cord Tissue Allogeneic – Related Autism Neurology 2024 Experimental Therapy Romania 17
    1388 Cord Tissue Autologous Autism Neurology 2024 Experimental Therapy Romania 7
    1389 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2024 Experimental Therapy Poland 61,9
    1390 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2024 Experimental Therapy Poland 45,4
    1391 Cord Tissue Allogeneic – Unrelated Amyotrophic lateral sclerosis Neurology 2024 Experimental Therapy Poland 56,9
    1392 Cord Tissue Allogeneic – Unrelated Graft-versus-host disease Hematology 2024 Experimental Therapy Poland 0,10
    1393 Cord Tissue Allogeneic – Unrelated Amyotrophic lateral sclerosis Neurology 2024 Experimental Therapy Poland 39,0
    1394 Cord Tissue Allogeneic – Unrelated GvHD Neurology 2024 Experimental Therapy Poland 9,2
    1395 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2024 Experimental Therapy Poland 5,11
    1396 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2024 Experimental Therapy Poland 13,10
    1397 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2024 Experimental Therapy Poland 1,9
    1398 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2024 Experimental Therapy Poland 7,11
    1399 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2024 Experimental Therapy Poland 1
    1400 Cord Tissue Allogeneic – Unrelated Cerebellar-spinal ataxia Neurology 2024 Experimental Therapy Poland 35,5